ArticleCancers2019

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer.

Zulrahman Erlangga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.